Frequently Asked Questions about Phio Pharmaceuticals Corp. (PHIO)

Name: Phio Pharmaceuticals Corp. (PHIO) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Phio Pharmaceuticals Corp. (PHIO) do?

Accepted Answer

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cel...

Question 2

Is Phio Pharmaceuticals Corp. (PHIO) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of PHIO reveals an Altman Z-Score of -3.81 and a Piotroski F-Score of 2/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if PHIO fits their risk profile.

Question 3

What is the current P/E ratio for PHIO?

Accepted Answer

As of the latest trading session, Phio Pharmaceuticals Corp. (PHIO) has a trailing P/E ratio of -1.66.

Question 4

Who is the CEO of Phio Pharmaceuticals Corp.?

Accepted Answer

The current Chief Executive Officer of Phio Pharmaceuticals Corp. is Robert J. Bitterman.

Question 5

What was PHIO's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Phio Pharmaceuticals Corp. reported annual revenues of $0.00B (2025), $0.00B (2024), $0.00B (2023), $0.00B (2022), $0.00B (2021) respectively.

Question 6

Does PHIO pay a dividend?

Accepted Answer

Phio Pharmaceuticals Corp. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does PHIO have?

Accepted Answer

In its latest reporting period, Phio Pharmaceuticals Corp. generated $-0.01B in Free Cash Flow against a total debt load of $N/A.

Question 8

What is the Price-to-Book (P/B) ratio of Phio Pharmaceuticals Corp.?

Accepted Answer

The Price-to-Book (P/B) ratio for Phio Pharmaceuticals Corp. (PHIO) is currently 0.72.

Question 9

What is the Price-to-Sales (P/S) ratio of PHIO?

Accepted Answer

Based on trailing twelve-month data, Phio Pharmaceuticals Corp. (PHIO) trades at a Price-to-Sales (P/S) ratio of 0.00.

Question 10

What is Phio Pharmaceuticals Corp.'s Return on Equity (ROE)?

Accepted Answer

Phio Pharmaceuticals Corp. (PHIO) has a Return on Equity (ROE) of -66.59%, representing its profitability relative to shareholder equity.

Period	Gross Profit	Op. Income	Net Income	EPS
2025-12	-3K	-9.2M	-8.7M	-1.45
2024-12	-3.6M	-7.4M	-7.2M	-0.91
2023-12	-6.3M	-10.8M	-10.8M	-46.87
2022-12	-7M	-11.5M	-11.5M	-89.61
2021-12	-8.9M	-13.5M	-13.3M	-111.32